WellTheory today announced the close of $5 million in new funding and the successful rollout of its proprietary AI tools, Care Hub and Care Scribe, across its care operations. New investors Samsung Next, Opal Ventures, and Up2 Fund joined the round, with continued support from existing investors Accel, OVO Fund, and BoxGroup..

WellTheory 今天宣布完成了 500 万美元的新一轮融资，并成功在其护理业务中推出了其专有的 AI 工具 Care Hub 和 Care Scribe。新投资者 Samsung Next、Opal Ventures 和 Up2 Fund 加入了本轮融资，现有投资者 Accel、OVO Fund 和 BoxGroup 继续提供支持。

WellTheory is a virtual care platform reversing the autoimmune epidemic by filling the gaps left behind in traditional healthcare. WellTheory offers a research-backed proprietary program that addresses the root cause of autoimmunity and treats the whole person with the aim to reduce symptoms, improve quality of life, and lower costs.

WellTheory是一个虚拟护理平台，通过填补传统医疗保健留下的空白来扭转自身免疫疾病的流行。WellTheory提供了一个基于研究的专有项目，针对自身免疫的根本原因进行治疗，并以整体方式对待患者，旨在减轻症状、改善生活质量并降低成本。

WellTheory's platform centers around evidence-based, high-touch care led by an interdisciplinary team of autoimmune experts, including licensed registered dietitians and board-certified health coaches. It's an anti-symptom-masking model that goes beyond the pill, built by autoimmune patients and validated by decades of clinical research..

WellTheory的平台围绕着由自身免疫专家组成的跨学科团队提供的基于证据的高接触护理，其中包括注册营养师和认证健康教练。这是一种反症状掩盖模式，超越了药物治疗，由自身免疫患者创建，并经过数十年临床研究验证。